国产+免费+日韩欧美,日本人妻无码欧美激情美乳中文,日本美女黄色录像电影,小说诱惑免费看,国产在线精品无码av不卡顿四虎,暑假调教我的妺妺h肉奴视频,婆媳双飞,免费观看18禁视频网站,一本色道久久综合一

A66

    
99%

(2S)-N1-(5-(2-tert-butylthiazol-4-yl)-4-methylthiazol-2-yl)pyrrolidine-1,2-dicarboxamide

源葉(MedMol)
S80135 一鍵復(fù)制產(chǎn)品信息
1166227-08-2
C17H23N5O2S2
393.53
(2S)-N1-(2-叔丁基-4'-甲基[4,5'-聯(lián)噻唑]-2'-基)-1,2-吡咯烷二甲酰胺;A-66; CS-0477; (S)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-[(2-tert-butyl-4'-methyl-[4,5']bithiazolyl-2'-yl)-amide];
貨號 規(guī)格 價格 上海 北京 武漢 南京 購買數(shù)量
S80135-5mg 99% ¥420.00 9 - - -
S80135-10mg 99% ¥670.00 10 - - -
S80135-50mg 99% ¥1950.00 6 - - -
產(chǎn)品介紹 參考文獻 質(zhì)檢證書(COA) 摩爾濃度計算器 相關(guān)產(chǎn)品

產(chǎn)品介紹

A66 is a highly specific and selective p110α inhibitor with an IC50 of 32 nM.

產(chǎn)品描述: A66 is a highly specific and selective p110α inhibitor with an IC50 of 32 nM.
靶點: p110α:32 nM (IC50);p110α E545K:30 nM (IC50);p110α H1047R:43 nM (IC50);p110γ:3480 nM (IC50);PI3K-C2β:462 nM (IC50);PI4Kβ:236 nM (IC50);PI3K
體內(nèi)研究: The optimal dosing strategy for xenograft studies is determined by investigating the drug pharmacokinetics after a dose of 10 mg/kg of body weight by intraperitoneal injection in CD-1 mice. Despite a short half-life of only 0.42 h, the large Cmax (8247 nM) of A66 S that is reached 30 min after dosing ensured that the AUC0-inf (area under the curve from zero time to infinity) (6809 nM?h) is similar to that of BEZ-235 (7333 nM?h), which has a longer half-life of 2.73 h. Furthermore, the A66 on SK-OV-3 tumour tissue is tested using a single dose of 100 mg/kg of body weight to determine whether a long-lasting effect of the drug could be achieved on target tissues. These studies show that A66 causes a profound reduction in the phosphorylation of Akt/PKB and p70 S6 kinase, but not of ERK (extracellular-signal-regulated kinase), at both 1 and 6 h after dosing. Levels of A66 in plasma are determined to be 21.1±1.2 μM and 9.1±1.1 μM at 1 and 6 h after drug injection, whereas levels of A66 in the tumor are 22.7±2.1 μM and 16.0±1.3 μM at the same time points
參考文獻: 1. Jamieson S, et al. A drug targeting only p110α can block phosphoinositide 3-kinase signalling and tumour growth in certain cell types. Biochem J, 2011, 438(1), 53-62. 2. Sun M, et al. Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha. Proc Natl Acad Sci U S A, 2010, 107(35), 15547-15552.
溶解性: DMSO  :  50  mg/mL  (127.06  mM;  Need  ultrasonic)
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.541 ml 12.706 ml 25.411 ml
5 mM 0.508 ml 2.541 ml 5.082 ml
10 mM 0.254 ml 1.271 ml 2.541 ml
50 mM 0.051 ml 0.254 ml 0.508 ml
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。

參考文獻

質(zhì)檢證書(COA)

如何獲取質(zhì)檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號:JS298415 貨號:S20001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關(guān)產(chǎn)品